Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Vnus Medical Technologies has presented positive clinical performance data from the Recovery trial that affirmed the the efficacy and patient comfort levels of endovenous radiofrequency vein ablation using Vnus ClosureFAST.
Subscribe to our email newsletter
The Recovery trial is a single-blinded, randomized trial that compared the ClosureFAST catheter with endovenous laser ablation in 62 limbs.
Dr. Proebstle of Heidelberg, Germany, said: “Our study found the ratio of efficacy to side effects of the VNUS ClosureFAST catheter to be superior to any previous endovenous ablation device. In 223 cases where the ClosureFAST device was used, 96.7% of the veins remained sealed after one year using Kaplan-Meier analysis.”